The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate

Pterostilbene (3,5-dimethoxy-40-hydroxystilbene) is a potent oral antioxidant with a promising role in anti-cancer treatment. In endometrial cancer (EC), in vitro studies demonstrated a synergistic antiproliferative effect of pterostilbene (PT) with megestrol acetate (MA), a common treatment for EC....

ver descrição completa

Detalhes bibliográficos

Principais autores:	Rosemary N. Senguttuvan, Hyejin Cho, Xiwei Wu, Paul H. Frankel, Nora Ruel, Susan E. Yost, Mehdi Kebria, Ernest Han, Mihae Song, Maria de Leon, Marta Invernizzi, Melissa Eng, Raechelle Tinsley, Behrouz Salehian, Aimin Li, Daniel Schmolze, Sue Chang, Javier Arias-Stella, Thanh H. Dellinger
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2025-03-01
coleção:	Antioxidants
Assuntos:	megestrol acetate pterostilbene endometrial cancer clinical trial
Acesso em linha:	https://www.mdpi.com/2076-3921/14/3/345
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!